mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |